Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
87,692,308
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
49,723,793
-
Shares change
-
+19,485,314
-
Total reported value, excl. options
-
$506,193,882
-
Value change
-
+$199,453,477
-
Number of buys
-
46
-
Number of sells
-
-18
-
Price
-
$10.18
Significant Holders of Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN) as of Q4 2022
70 filings reported holding TERN - Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q4 2022.
Terns Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (TERN) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49,723,793 shares
of 87,692,308 outstanding shares and own 57% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7,619,135 shares), FMR LLC (7,378,641 shares), Vivo Capital, LLC (6,657,992 shares), VR Adviser, LLC (3,707,891 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3,448,275 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,851,287 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2,294,376 shares), Fairmount Funds Management LLC (2,040,000 shares), MILLENNIUM MANAGEMENT LLC (1,457,205 shares), and JPMORGAN CHASE & CO (1,207,151 shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.